Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myotonic Dystrophy Type 2”

65 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 65 results

Not applicableUnknownNCT04295031
What this trial is testing

Metformin in Older Adults With Type 2 Diabetes (AMEMET)

Who this might be right for
Diabetes Mellitus, Type 2
Associazione Medici Endocrinologi 1,500
Not applicableStudy completedNCT02287532
What this trial is testing

Evaluation of the DIABEO System in Poorly Controlled DM1 or DM2 Patients Treated With a Basal-bolus Insulin Regimen

Who this might be right for
Diabetes
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète 667
Testing effectiveness (Phase 2)Looking for participantsNCT06844214
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 50 Years of Age With Non-congenital Myotonic Dystrophy Type 1

Who this might be right for
Myotonic Dystrophy
Sanofi 32
Not applicableNot Yet RecruitingNCT07156331
What this trial is testing

Research on Effects of Drugs on Body Composition and Function With Imaging in Diabetes

Who this might be right for
Type 2 Diabetes
Kristin Clemens 20
Testing effectiveness (Phase 2)Study completedNCT05479981
What this trial is testing

Extension of AOC 1001-CS1 (MARINA) Study in Adult Myotonic Dystrophy Type 1 (DM1) Patients

Who this might be right for
DM1Muscular DystrophiesMyotonic Dystrophy+10 more
Avidity Biosciences, Inc. 37
Not applicableStudy completedNCT04473430
What this trial is testing

Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)

Who this might be right for
End-Stage Renal DiseaseType 2 Diabetes
Emory University 53
Not applicableEnrolling By InvitationNCT06605612
What this trial is testing

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more
LMU Klinikum 108
Large-scale testing (Phase 3)Study completedNCT03610412
What this trial is testing

Cinnamomum Cassia Effect on IGF1 and Metabolic Control in Patients With DM2 Without Glycemic Control Metformin Treated

Who this might be right for
Diabetes Mellitus, Type 2
Coordinación de Investigación en Salud, Mexico 28
Not applicableWithdrawnNCT03827434
What this trial is testing

CGM/Clarity Use, Glycemic Control and Clinical Outcomes

Who this might be right for
Diabetes MellitusHyperglycemiaHypoglycemia
University of Maryland, Baltimore
Not applicableActive Not RecruitingNCT05874635
What this trial is testing

Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022)

Who this might be right for
Weight LossMetabolic SyndromeDiabetes Mellitus, Type 2+4 more
Signos Inc 20,000
Early research (Phase 1)Study completedNCT01437813
What this trial is testing

BIOAVAILABILITY OF Glimepiride/Extended Release Metformin (GLI/METXR): High Fat Diet Study

Who this might be right for
Healthy
Laboratorios Silanes S.A. de C.V. 24
Large-scale testing (Phase 3)UnknownNCT03051243
What this trial is testing

Safety and Efficiency of Linagliptin (Trajenta) in the Setting of Internal Medicine Department

Who this might be right for
DM2
Rabin Medical Center 60
Post-approval studies (Phase 4)UnknownNCT04392557
What this trial is testing

Anti-inflammatory Status in DM2 Treated Patients

Who this might be right for
Diabetes Mellitus, Type 2
University of Catanzaro 36
Large-scale testing (Phase 3)WithdrawnNCT04700046
What this trial is testing

Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type 2

Who this might be right for
Myotonic Dystrophy Type 1 and Type 2
Lupin Ltd.
Not applicableNot Yet RecruitingNCT07128342
What this trial is testing

CGM Use in Non-insulin Patients With DM2

Who this might be right for
DiabetesType 2 Diabetes (T2DM)Obesity Type 2 Diabetes Mellitus+1 more
Milwaukee VA Medical Center 100
Not applicableStudy completedNCT00469287
What this trial is testing

Early Diagnosis of Diabetes Mellitus Type 2 (DM2)

Who this might be right for
Impaired Blood Glucose LevelOverweightObesity
TNO 50
Not applicableLooking for participantsNCT06638567
What this trial is testing

Postoperative Basal Bolus or Sliding Scale Insulin Regimen in DM2 and Its Effect on Surgical Site Infections.

Who this might be right for
Diabetes Mellitus, Type 2Surgical Site Infection
Abraham Hulst, MD, PhD 1,008
Testing effectiveness (Phase 2)Study completedNCT06624553
What this trial is testing

Satisfaction With FreeStyle Libre 2 Monitoring Versus Capillary Blood Glucose Monitoring in People With DM2

Who this might be right for
Diabetes Mellitus, Type 2
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 50
Testing effectiveness (Phase 2)Study completedNCT05027269
What this trial is testing

Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients

Who this might be right for
DM1Myotonic Dystrophy 1Myotonic Dystrophy+5 more
Avidity Biosciences, Inc. 38
Post-approval studies (Phase 4)Study completedNCT03074630
What this trial is testing

Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)

Who this might be right for
Diabetes Mellitus, Type 2Hypercholesterolemia
Amsterdam UMC, location VUmc 12
Load More Results